TerrAscend (TSNDF) Free Cash Flow (2021 - 2026)
TerrAscend's (TSNDF) quarterly Free Cash Flow came in at $7.6 million in Q1 2026, down 13.58% year-on-year from $8.8 million in Q1 2025, and down 59.23% on a QoQ basis from $18.7 million in Q4 2025.
TerrAscend (TSNDF) Free Cash Flow (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Free Cash Flow data on file, last reported at $7.6 million in Q1 2026.
- On a quarterly basis, Free Cash Flow fell 13.58% year-over-year to $7.6 million in Q1 2026; TTM through Mar 2026 was $24.1 million, a 36.06% decrease from a year earlier, with the FY2025 full-year figure at $25.3 million, down 35.67% from the prior year.
- Free Cash Flow for Q1 2026 stood at $7.6 million, down from $18.7 million in the prior quarter.
- Over the last five years, Free Cash Flow for TSNDF reached as high as $18.8 million in Q2 2024 and fell as low as -$27.3 million in Q2 2022.
- Historically, Free Cash Flow has averaged $2.0 million across 5 years, with a median of $5.8 million in 2023.
- Across the five-year window, Free Cash Flow slumped 702.24% in 2022 and jumped 739.79% in 2023, its largest moves.
- Year by year, Free Cash Flow stood at -$15.9 million in 2022, then soared by 111.46% to $1.8 million in 2023, then surged by 121.33% to $4.0 million in 2024, then soared by 363.12% to $18.7 million in 2025, then sank by 59.23% to $7.6 million in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were $7.6 million in Q1 2026, $18.7 million in Q4 2025, and $445000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 7.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.62 Mn |
| Mar 31, 2026 | 7.62 Mn |
| Dec 31, 2025 | 18.70 Mn |
| Dec 31, 2025 | 18.70 Mn |
| Sep 30, 2025 | 445,000.00 |
| Sep 30, 2025 | 445,000.00 |
| Jun 30, 2025 | -2.65 Mn |
| Jun 30, 2025 | -2.65 Mn |
| Mar 31, 2025 | 8.82 Mn |
| Mar 31, 2025 | 8.82 Mn |
| Dec 31, 2024 | 4.04 Mn |
| Dec 31, 2024 | 4.04 Mn |
| Sep 30, 2024 | 6.09 Mn |
| Sep 30, 2024 | 6.09 Mn |
| Jun 30, 2024 | 18.77 Mn |
| Jun 30, 2024 | 18.77 Mn |
| Mar 31, 2024 | 10.46 Mn |
| Mar 31, 2024 | 10.46 Mn |
| Dec 31, 2023 | 1.82 Mn |
| Dec 31, 2023 | 1.82 Mn |